# US 2022/0007972 A1 · Non-invasive monitoring system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0007972 A1
- Document ID: US20220007972A1
- Status: Published application
- Kind: A1
- Application number: 17/294,279
- Filed: 2019-11-14
- Published: 2022-01-13
- Earliest claimed: 2018-11-14
- Assignees: Aerbetic, Inc.
- Applicants: Aerbetic, Inc.
- Inventors: Arnar THORS; Eric HOUSH; Lloyd COOPER; Matt FITZGERALD
- Web page: https://patentgrep.com/patent/US20220007972A1

## CPC

- A61B 5/1477: non-invasive
- A61B 5/083: Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B 5/097: Devices for facilitating collection of breath or for directing breath into or through measuring devices
- A61B 5/14517: {for sweat}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/4866: {Evaluating metabolism (using breath test A61B5/083)}
- A61B 5/681: {Wristwatch-type devices}
- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A wearable device for non-invasive monitoring of the presence, amount, and/or concentration of an analyte in a sample from a user of the device is described. The analyte is selected to be indicative of or related to a physiological status of a user. Relevant physiological status include hypoglycemia, infection, respiratory infection, urinary infection, gastrointestinal infection, obesity, diabetes, type I diabetes and type II diabetes.

## Claims

### Claim 1

A method of evaluating a physiological status of a user by non-invasive monitoring of at least one analyte in a sample from the user containing the at least one analyte, the method comprising:
a. providing a wearable device, wherein the user wears the device;
b. exposing a sensor system of the wearable device to the sample;
c. detecting the at least one analyte via the sensor system, wherein the sensor system generates a signal in the presence of the at least one analyte;
d. analyzing the signal to determine the presence, amount, or concentration of the at least one analyte to produce a result; and
e. optionally performing at least one of the steps from the group consisting of:
i. providing the result to the user;
ii. alerting the user of the result; and
iii. notifying the user if the result is within an acceptable range or outside of an acceptable range for the physiological status.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method reduces the risk of user non-compliance.

### Claim 3 (depends on 1)

The method of claim 1, wherein the sample is an indirect sample.

### Claim 4 (depends on 1)

The method of claim 1, wherein the sample is ambient air comprising at least one analyte emanating from the user.

### Claim 5 (depends on 1)

The method of claim 1, wherein the physiological status is a physiological status from the group consisting of hypoglycemia, an infection, a respiratory infection, a urinary infection, a gastrointestinal infection, obesity, diabetes, type I diabetes, and type II diabetes.

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The methods of claim 1, wherein the analyte is at least one volatile organic compound.

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13 (depends on 9)

The method of claim 9, wherein the at least one volatile organic compound is selected from the group consisting of acetone, methyl nitrate, pentyl nitrate, ethanol, methanol, propanol, methane, propane, ethyl benzene, isoprene, O-xylene, M/P-xylene, formaldehyde, and acetaldehyde.

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The method of any claim 1, wherein the non-invasive monitoring is accomplished without requiring the user to exhale directly into the device.

### Claim 21

(canceled)

### Claim 22 (depends on 1)

The method of claim 1, wherein the non-invasive monitoring is accomplished without requiring an action of the user to initiate the monitoring process, to complete the monitoring process, to determine a result of the monitoring process, or view a result.

### Claim 23

A wearable device for detecting an analyte in a sample, the wearable device comprising:
a. a housing;
b. an inlet port;
c. a chamber in the interior of the housing;
d. an inlet passage having a first end in fluid communication with the inlet port and a second end in fluid communication with the chamber;
e. a sensor system; and
f. a controller in communication with the sensor system.

### Claim 24 (depends on 23)

The wearable device of claim 23, further comprising at least one component selected from the group consisting of a wireless communication module, a membrane to cover the inlet port, an exit port, a membrane to cover the exit port, a pump assembly, a user input, and a notification module.

### Claim 25 (depends on 23)

The wearable device of claim 23, wherein the sensor system comprises a plurality of individual sensors.

### Claim 26 (depends on 25)

The wearable device of claim 25, wherein each individual sensor generates a signal in the presence of an analyte which binds the sensor.

### Claim 27 (depends on 23)

The wearable device of claim 23, wherein each individual sensor comprises a sensor material.

### Claim 28 (depends on 27)

The wearable device of claim 27, wherein the sensor material comprises at least one material selected from the group consisting of polypyrrole, low-density polyethylene, poly(ethylene-block-ethylene oxide), polyethylene glycol, polymethylmethacrylate, and poly(vinylidene fluoride-hexafluoropropylene).

### Claim 29

(canceled)

### Claim 30 (depends on 28)

The wearable device of claim 28, wherein each individual sensor comprises an electrode and a sensor material deposited onto the electrode.

### Claim 31 (depends on 30)

The wearable device of claim 30, wherein the sensor material is material selected from the group consisting of TiO2, SnO2, Cr2O3, Mn2O3, Co3O4, NiO, CuO, SrO, In2O3, WO3, V2O3, Fe2O3, GeO2, Nb2O5, MoO3, Ta2O5, La2O3, CeO2, and Nd2O3, and optionally containing a dopant selected from the group consisting of: tungsten, palladium, platinum, titanium, lanthanum, and zinc.

### Claim 32 (depends on 30)

The wearable device of claim 30, wherein the sensor material is a nano-structured material.

### Claim 33 (depends on 23)

The wearable device of claim 23, wherein the inlet passage comprises a restriction point.

### Claim 34 (depends on 23)

The wearable device of claim 23, wherein the device is configured to evaluate a physiological status of a user wearing the device.

### Claim 35

(canceled)

### Claim 36 (depends on 23)

The wearable device of claim 23, wherein the analyte is at least one volatile organic compound.

### Claim 37

(canceled)

### Claim 38

(canceled)

### Claim 39 (depends on 36)

The wearable device of claim 36, wherein the at least one volatile organic compound is selected from the group consisting of acetone, methyl nitrate, pentyl nitrate, ethanol, methanol, propanol, methane, propane, ethyl benzene, isoprene, O-xylene, M/P-xylene, formaldehyde, and acetaldehyde, or any combination of the foregoing.

### Claim 40

(canceled)

### Claim 41

(canceled)

### Claim 42

(canceled)

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45

(canceled)
